Studies in humans have shown that mutations in TET2 are thought to be the most relevant of the various TETs in developing hematological malignancies [32,33,34] and are also associated with increased risks of autoimmunity in myelodysplastic syndrome patients [35]. Here, TET2 is linked to hematologic disorder.